Labopharm Inc.
1200 Chomedey Boulevard, Suite 500
Laval
Quebec
H7V 3Z3
Canada
Tel: 450-686-1017
Fax: 450-686-9141
Website: http://www.labopharm.com/
Email: gderome@labopharm.com
165 articles about Labopharm Inc.
-
Labopharm Inc. Shareholders Vote To Approve Acquisition By Paladin Labs Inc.
10/5/2011
-
Paladin Labs Inc. to Buy Labopharm Inc. for $20.5 Million
8/17/2011
-
Labopharm Inc.'s Joint Venture Announces Major Layoffs, Cuts Sales Force in Half
6/24/2011
-
Labopharm Inc. Announces Intention to Delist From NASDAQ
6/22/2011
-
Labopharm Inc. Reports Financial Results For First Quarter 2011
5/4/2011
-
Labopharm Inc. to Host Conference Call Wednesday, May 4, 2011 at 8:30 A.M. (ET)
4/29/2011
-
Labopharm Inc. Continues Strategic Review After Reduced Workforce, Mulls Future of Oleptro
4/29/2011
-
Labopharm Inc. Receives Notice From Nasdaq Regarding Minimum Market Value Of Listed Securities
4/4/2011
-
Labopharm Inc. Cuts Nearly 30 Percent of Its Workforce to Reduce Operating Costs; Appoints New CFO
3/22/2011
-
Labopharm Inc. Announces Appointment of New President & CEO
3/14/2011
-
Labopharm Inc. Reports Progress And Financial Results For Fourth Quarter 2010
2/24/2011
-
Labopharm Inc. Says It Has Received More Than $5 Million In Payments From Purdue Pharma L.P. For Ryzolt
1/3/2011
-
Labopharm Inc.'s Antidepressant Drug, Oleptro, Gets Generic Threat From Actavis
11/12/2010
-
Labopharm Inc. Posts Wider Loss, Revenue Rises
11/11/2010
-
Labopharm Inc., Paladin Labs Inc. Ink Distribution Deal; Labopharm to Receive up to C$7.2 Million in Milestones
10/14/2010
-
Labopharm Inc. Net Loss Widens
8/13/2010
-
Labopharm Sets U.S. Joint Venture with Italy's Grupo Angelini; Deal for Trazodone worth C$92 Million
4/29/2010
-
Labopharm to Host Conference Call Wednesday, May 5, 2010 at 8:30 a.m. (ET)
4/26/2010
-
Labopharm Introduces INTELLITAB(TM): A Proprietary Abuse-Misuse-Deterrent Technology Platform
4/21/2010
-
Labopharm Introduces INTELLITAB(TM): A Proprietary Abuse-Misuse-Deterrent Technology Platform
4/21/2010